{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:36:50Z","timestamp":1772325410275,"version":"3.50.1"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11906-015-0569-6","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T08:04:10Z","timestamp":1436342650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?"],"prefix":"10.1007","volume":"17","author":[{"given":"Henry","family":"Fok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Kennedy","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"key":"569_CR1","unstructured":"A global brief on hypertension: Silent Killer, global public health crisis. 2013."},{"issue":"3","key":"569_CR2","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS et al. Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28\u2013e292.","journal-title":"Circulation"},{"issue":"28","key":"569_CR3","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC). Eur Heart J. 2013;34(28):2159\u2013219.","journal-title":"Eur Heart J"},{"issue":"6","key":"569_CR4","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.HYP.30.6.1410","volume":"30","author":"A Benetos","year":"1997","unstructured":"Benetos A et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997;30(6):1410\u20135.","journal-title":"Hypertension"},{"issue":"3","key":"569_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/01.HYP.23.3.395","volume":"23","author":"S Madhavan","year":"1994","unstructured":"Madhavan S et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23(3):395\u2013401.","journal-title":"Hypertension"},{"issue":"4","key":"569_CR6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.13.4.392","volume":"13","author":"B Darne","year":"1989","unstructured":"Darne B et al. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension. 1989;13(4):392\u2013400.","journal-title":"Hypertension"},{"issue":"4","key":"569_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00004872-199504000-00006","volume":"13","author":"J Fang","year":"1995","unstructured":"Fang J et al. Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens. 1995;13(4):413\u20139.","journal-title":"J Hypertens"},{"issue":"3","key":"569_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0735-1097(99)00586-0","volume":"35","author":"A Benetos","year":"2000","unstructured":"Benetos A et al. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol. 2000;35(3):673\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"569_CR9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archinte.160.8.1085","volume":"160","author":"J Blacher","year":"2000","unstructured":"Blacher J et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med. 2000;160(8):1085\u20139.","journal-title":"Arch Intern Med"},{"issue":"18","key":"569_CR10","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/archinte.160.18.2765","volume":"160","author":"RJ Glynn","year":"2000","unstructured":"Glynn RJ et al. Pulse pressure and mortality in older people. Arch Intern Med. 2000;160(18):2765\u201372.","journal-title":"Arch Intern Med"},{"issue":"3","key":"569_CR11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/01.HYP.34.3.375","volume":"34","author":"MJ Domanski","year":"1999","unstructured":"Domanski MJ et al. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension. 1999;34(3):375\u201380.","journal-title":"Hypertension"},{"issue":"2","key":"569_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1047-2797(98)00034-9","volume":"9","author":"ML Lee","year":"1999","unstructured":"Lee ML, Rosner BA, Weiss ST. Relationship of blood pressure to cardiovascular death: the effects of pulse pressure in the elderly. Ann Epidemiol. 1999;9(2):101\u20137.","journal-title":"Ann Epidemiol"},{"issue":"9207","key":"569_CR13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(99)07330-4","volume":"355","author":"JA Staessen","year":"2000","unstructured":"Staessen JA et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355(9207):865\u201372.","journal-title":"Lancet"},{"issue":"1","key":"569_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004872-200201000-00021","volume":"20","author":"J Gasowski","year":"2002","unstructured":"Gasowski J et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens. 2002;20(1):145\u201351.","journal-title":"J Hypertens"},{"issue":"4","key":"569_CR15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/01.CIR.100.4.354","volume":"100","author":"SS Franklin","year":"1999","unstructured":"Franklin SS et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation. 1999;100(4):354\u201360.","journal-title":"Circulation"},{"issue":"6","key":"569_CR16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.amjhyper.2005.12.009","volume":"19","author":"V Palmieri","year":"2006","unstructured":"Palmieri V et al. Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the Strong Heart Study. Am J Hypertens. 2006;19(6):601\u20137.","journal-title":"Am J Hypertens"},{"issue":"3","key":"569_CR17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.HYP.37.3.869","volume":"37","author":"SS Franklin","year":"2001","unstructured":"Franklin SS et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on national health and nutrition examination survey (NHANES) III. Hypertension. 2001;37(3):869\u201374.","journal-title":"Hypertension"},{"issue":"23","key":"569_CR18","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.105.588020","volume":"113","author":"PS Sever","year":"2006","unstructured":"Sever PS et al. Blood pressure reduction is not the only determinant of outcome. Circulation. 2006;113(23):2754\u201372. discussion 2773\u20134.","journal-title":"Circulation"},{"issue":"9489","key":"569_CR19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(05)67186-3","volume":"366","author":"NR Poulter","year":"2005","unstructured":"Poulter NR et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the anglo-scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA). Lancet. 2005;366(9489):907\u201313.","journal-title":"Lancet"},{"issue":"9311","key":"569_CR20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahlof","year":"2002","unstructured":"Dahlof B et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995\u20131003.","journal-title":"Lancet"},{"issue":"3","key":"569_CR21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-2125.1999.00037.x","volume":"48","author":"M Dawes","year":"1999","unstructured":"Dawes M et al. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension. Br J Clin Pharmacol. 1999;48(3):460\u20133.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"569_CR22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00004872-200203000-00025","volume":"20","author":"K Zander van der","year":"2002","unstructured":"van der Zander K et al. Nitric oxide and potassium channels are involved in brain natriuretic peptide induced vasodilatation in man. J Hypertens. 2002;20(3):493\u20139.","journal-title":"J Hypertens"},{"issue":"1","key":"569_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2125.1978.tb01595.x","volume":"5","author":"JG Collier","year":"1978","unstructured":"Collier JG, Lorge RE, Robinson BF. Comparison of effects of tolmesoxide (RX71107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man. Br J Clin Pharmacol. 1978;5(1):35\u201344.","journal-title":"Br J Clin Pharmacol"},{"key":"569_CR24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1113\/jphysiol.1989.sp017630","volume":"412","author":"N Benjamin","year":"1989","unstructured":"Benjamin N et al. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol. 1989;412:543\u201355.","journal-title":"J Physiol"},{"issue":"5","key":"569_CR25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2125.1980.tb01784.x","volume":"10","author":"BF Robinson","year":"1980","unstructured":"Robinson BF, Dobbs RJ, Kelsey CR. Effects of nifedipine on resistance vessels, arteries and veins in man. Br J Clin Pharmacol. 1980;10(5):433\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"569_CR26","unstructured":"Nichols WW, O\u2019Rourke MF, McDonald\u2019s blood flow in arteries: theoretical, experimental and clinical applications. 2005, 5th Edition, Hodder Arnold."},{"issue":"5","key":"569_CR27","first-page":"S3","volume":"17","author":"HR Black","year":"1999","unstructured":"Black HR et al. The first report of the systolic and pulse pressure (SYPP) working group. J Hypertens Suppl. 1999;17(5):S3\u201314.","journal-title":"J Hypertens Suppl"},{"issue":"5","key":"569_CR28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.35.5.1021","volume":"35","author":"JL Izzo Jr","year":"2000","unstructured":"Izzo Jr JL, Levy D, Black HR. Clinical advisory statement. Importance of systolic blood pressure in older americans. Hypertension. 2000;35(5):1021\u20134.","journal-title":"Hypertension"},{"issue":"8","key":"569_CR29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/00004872-200208000-00001","volume":"20","author":"G Mancia","year":"2002","unstructured":"Mancia G, Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens. 2002;20(8):1461\u20134.","journal-title":"J Hypertens"},{"issue":"7","key":"569_CR30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/HJH.0b013e328339f9c5","volume":"28","author":"T Bejan-Angoulvant","year":"2010","unstructured":"Bejan-Angoulvant T et al. Treatment of hypertension in patients 80 years and older: the lower the better? a meta-analysis of randomized controlled trials. J Hypertens. 2010;28(7):1366\u201372.","journal-title":"J Hypertens"},{"issue":"3","key":"569_CR31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","volume":"122","author":"DS Wald","year":"2009","unstructured":"Wald DS et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290\u2013300.","journal-title":"Am J Med"},{"issue":"6","key":"569_CR32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-136-6-200203190-00007","volume":"136","author":"F Boutitie","year":"2002","unstructured":"Boutitie F et al. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med. 2002;136(6):438\u201348.","journal-title":"Ann Intern Med"},{"issue":"5149","key":"569_CR33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0140-6736(00)95580-6","volume":"199","author":"JCH Bramwell","year":"1922","unstructured":"Bramwell JCH, A.V. Velocity of transmission of the pulse-wave. Lancet. 1922;199(5149):891\u20132.","journal-title":"Lancet"},{"issue":"1","key":"569_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-6-1-12","volume":"6","author":"CJ Wiggers","year":"1932","unstructured":"Wiggers CJ. Physical and physiological aspects of arteriosclerosis and hypertension*. Ann Intern Med. 1932;6(1):12\u201330.","journal-title":"Ann Intern Med"},{"issue":"4","key":"569_CR35","doi-asserted-by":"crossref","first-page":"H1358","DOI":"10.1152\/ajpheart.00175.2002","volume":"284","author":"JJ Wang","year":"2003","unstructured":"Wang JJ et al. Time-domain representation of ventricular-arterial coupling as a windkessel and wave system. Am J Physiol Heart Circ Physiol. 2003;284(4):H1358\u201368.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"569_CR36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/HYPERTENSIONAHA.113.02838","volume":"64","author":"JE Davies","year":"2014","unstructured":"Davies JE et al. Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of anglo-scandinavian cardiac outcomes trial. Hypertension. 2014;64(1):60\u20138.","journal-title":"Hypertension"},{"issue":"5","key":"569_CR37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jacc.2011.10.871","volume":"59","author":"M Cecelja","year":"2012","unstructured":"Cecelja M et al. Progression of central pulse pressure over 1 decade of aging and its reversal by nitroglycerin a twin study. J Am Coll Cardiol. 2012;59(5):475\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"569_CR38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/HYPERTENSIONAHA.114.04127","volume":"64","author":"A Scuteri","year":"2014","unstructured":"Scuteri A et al. Longitudinal perspective on the conundrum of central arterial stiffness, blood pressure, and aging. Hypertension. 2014;64(6):1219\u201327.","journal-title":"Hypertension"},{"issue":"7","key":"569_CR39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2013.09.063","volume":"63","author":"Y Ben-Shlomo","year":"2014","unstructured":"Ben-Shlomo Y et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"569_CR40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/HYPERTENSIONAHA.108.126615","volume":"53","author":"CM McEniery","year":"2009","unstructured":"McEniery CM et al. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension. 2009;53(3):524\u201331.","journal-title":"Hypertension"},{"issue":"16","key":"569_CR41","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1161\/01.CIR.0000033824.02722.F7","volume":"106","author":"JK Cruickshank","year":"2002","unstructured":"Cruickshank JK et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106(16):2085\u201390.","journal-title":"Circulation"},{"issue":"9","key":"569_CR42","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/01.CIR.0000139903.29522.8D","volume":"110","author":"M Ronnback","year":"2004","unstructured":"Ronnback M et al. Altered age-related blood pressure pattern in type 1 diabetes. Circulation. 2004;110(9):1076\u201382.","journal-title":"Circulation"},{"issue":"1","key":"569_CR43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.HYP.0000047464.66901.60","volume":"41","author":"A Mahmud","year":"2003","unstructured":"Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 2003;41(1):183\u20137.","journal-title":"Hypertension"},{"issue":"3","key":"569_CR44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","volume":"30","author":"LM Bortel Van","year":"2012","unstructured":"Van Bortel LM et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445\u20138.","journal-title":"J Hypertens"},{"issue":"2","key":"569_CR45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.HYP.35.2.637","volume":"35","author":"JJ Heijden-Spek van der","year":"2000","unstructured":"van der Heijden-Spek JJ et al. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension. 2000;35(2):637\u201342.","journal-title":"Hypertension"},{"issue":"7","key":"569_CR46","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2337\/diacare.26.7.2133","volume":"26","author":"JD Cameron","year":"2003","unstructured":"Cameron JD et al. The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care. 2003;26(7):2133\u20138.","journal-title":"Diabetes Care"},{"issue":"2","key":"569_CR47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.112.194779","volume":"60","author":"C Vlachopoulos","year":"2012","unstructured":"Vlachopoulos C et al. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012;60(2):556\u201362.","journal-title":"Hypertension"},{"issue":"13","key":"569_CR48","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2010.09.079","volume":"57","author":"M Cecelja","year":"2011","unstructured":"Cecelja M et al. Arterial stiffening relates to arterial calcification but not to noncalcified atheroma in women. A Twin Study J Am Coll Cardiol. 2011;57(13):1480\u20136.","journal-title":"A Twin Study J Am Coll Cardiol"},{"issue":"10","key":"569_CR49","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.amjhyper.2007.05.013","volume":"20","author":"D Ge","year":"2007","unstructured":"Ge D et al. Heritability of arterial stiffness in black and white American youth and young adults. Am J Hypertens. 2007;20(10):1065\u201372.","journal-title":"Am J Hypertens"},{"issue":"3","key":"569_CR50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/01.CIR.0000022663.26468.5B","volume":"106","author":"CJ O\u2019Donnell","year":"2002","unstructured":"O\u2019Donnell CJ et al. Evidence for heritability of abdominal aortic calcific deposits in the Framingham Heart Study. Circulation. 2002;106(3):337\u201341.","journal-title":"Circulation"},{"issue":"14","key":"569_CR51","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.CIR.0000060543.64250.80","volume":"107","author":"HM Gardiner","year":"2003","unstructured":"Gardiner HM et al. Twin-twin transfusion syndrome: the influence of intrauterine laser photocoagulation on arterial distensibility in childhood. Circulation. 2003;107(14):1906\u201311.","journal-title":"Circulation"},{"issue":"3","key":"569_CR52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1017\/S204017441200013X","volume":"3","author":"HM Gardiner","year":"2012","unstructured":"Gardiner HM et al. Vascular programming in twins: the effects of chorionicity and fetal therapy for twin-to-twin transfusion syndrome. J Dev Orig Health Dis. 2012;3(3):182\u20139.","journal-title":"J Dev Orig Health Dis"},{"issue":"6","key":"569_CR53","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/uog.13279","volume":"43","author":"HM Gardiner","year":"2014","unstructured":"Gardiner HM et al. Cardiac function in 10-year-old twins following different fetal therapies for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol. 2014;43(6):652\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"569_CR54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/14767058.2011.573830","volume":"25","author":"M Pan","year":"2012","unstructured":"Pan M et al. Outcome of monochorionic twin pregnancies with abnormal umbilical artery Doppler between 16 and 20 weeks of gestation. J Matern Fetal Neonatal Med. 2012;25(3):277\u201380.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"569_CR55","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/HYPERTENSIONAHA.109.137653","volume":"54","author":"M Cecelja","year":"2009","unstructured":"Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54(6):1328\u201336.","journal-title":"Hypertension"},{"key":"569_CR56","doi-asserted-by":"crossref","unstructured":"Akhtar R et al. Characterizing the elastic properties of tissues. Mater Today (Kidlington). 2011;14(3):96\u2013105.","DOI":"10.1016\/S1369-7021(11)70059-1"},{"key":"569_CR57","doi-asserted-by":"crossref","unstructured":"Akhtar R et al. Localized micro- and nano-scale remodelling in the diabetic aorta. Acta Biomater. 2014;10(11):4843\u201351.","DOI":"10.1016\/j.actbio.2014.07.001"},{"issue":"5","key":"569_CR58","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.ATV.0000160548.78317.29","volume":"25","author":"SJ Zieman","year":"2005","unstructured":"Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25(5):932\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"569_CR59","unstructured":"Safar, ME, O\u2019Rourke MF. Arterial stiffness in hypertension. 1st edition Handbook of Hypertension, eds. B.W.H.R. J.L. Vol. 23. 2006: Elsevier. 598."},{"issue":"12","key":"569_CR60","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1084\/jem.192.12.1731","volume":"192","author":"B Loo van der","year":"2000","unstructured":"van der Loo B et al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 2000;192(12):1731\u201344.","journal-title":"J Exp Med"},{"issue":"4","key":"569_CR61","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1161\/01.RES.0000012569.55432.02","volume":"90","author":"H Mollnau","year":"2002","unstructured":"Mollnau H et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide\/cGMP signaling. Circ Res. 2002;90(4):E58\u201365.","journal-title":"Circ Res"},{"issue":"3","key":"569_CR62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.CIR.101.3.305","volume":"101","author":"M Usui","year":"2000","unstructured":"Usui M et al. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation. 2000;101(3):305\u201310.","journal-title":"Circulation"},{"issue":"1","key":"569_CR63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004872-199109010-00003","volume":"9","author":"H Kato","year":"1991","unstructured":"Kato H et al. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9(1):17\u201322.","journal-title":"J Hypertens"},{"issue":"2","key":"569_CR64","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI115881","volume":"90","author":"GH Gibbons","year":"1992","unstructured":"Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90(2):456\u201361.","journal-title":"J Clin Invest"},{"issue":"12 Pt 1","key":"569_CR65","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0895-7061(97)00301-4","volume":"10","author":"J Blacher","year":"1997","unstructured":"Blacher J et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens. 1997;10(12 Pt 1):1326\u201334.","journal-title":"Am J Hypertens"},{"issue":"2","key":"569_CR66","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/HYPERTENSIONAHA.111.185496","volume":"59","author":"L Paulis","year":"2012","unstructured":"Paulis L et al. Direct angiotensin II type 2 receptor stimulation in Nomega-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling. Hypertension. 2012;59(2):485\u201392. This study showed that chronic angiotensin II type 2 receptor stimulation in rats prevented arterial stiffening and the effects were additive to angiotensin type 1 receptor blockade.","journal-title":"Hypertension"},{"issue":"5","key":"569_CR67","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.HYP.31.5.1083","volume":"31","author":"JW Gu","year":"1998","unstructured":"Gu JW et al. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension. 1998;31(5):1083\u20137.","journal-title":"Hypertension"},{"issue":"11","key":"569_CR68","first-page":"1199","volume":"11","author":"P Draaijer","year":"1993","unstructured":"Draaijer P et al. Vascular distensibility and compliance in salt-sensitive and salt-resistant borderline hypertension. J Hypertens. 1993;11(11):1199\u2013207.","journal-title":"J Hypertens"},{"issue":"5 Pt 2","key":"569_CR69","first-page":"H1423","volume":"274","author":"C Partovian","year":"1998","unstructured":"Partovian C et al. Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin. Am J Physiol. 1998;274(5 Pt 2):H1423\u20138.","journal-title":"Am J Physiol"},{"issue":"2\u20133","key":"569_CR70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0021-9150(92)90132-Z","volume":"97","author":"JT Powell","year":"1992","unstructured":"Powell JT, Vine N, Crossman M. On the accumulation of D-aspartate in elastin and other proteins of the ageing aorta. Atherosclerosis. 1992;97(2\u20133):201\u20138.","journal-title":"Atherosclerosis"},{"issue":"12","key":"569_CR71","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/eurheartj\/ehs057","volume":"33","author":"A Virdis","year":"2012","unstructured":"Virdis A et al. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J. 2012;33(12):1530\u20138.","journal-title":"Eur Heart J"},{"issue":"5","key":"569_CR72","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.HYP.0000186331.47557.ae","volume":"46","author":"GF Mitchell","year":"2005","unstructured":"Mitchell GF et al. Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition. Hypertension. 2005;46(5):1111\u20137.","journal-title":"Hypertension"},{"issue":"25","key":"569_CR73","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1161\/01.CIR.0000020500.77568.3C","volume":"105","author":"GF Mitchell","year":"2002","unstructured":"Mitchell GF et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation. 2002;105(25):2955\u201361.","journal-title":"Circulation"},{"issue":"3","key":"569_CR74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.jhh.1000581","volume":"12","author":"J Topouchian","year":"1998","unstructured":"Topouchian J et al. Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study. J Hum Hypertens. 1998;12(3):181\u20137.","journal-title":"J Hum Hypertens"},{"issue":"6","key":"569_CR75","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/HYPERTENSIONAHA.108.111674","volume":"51","author":"J Karalliedde","year":"2008","unstructured":"Karalliedde J et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension. 2008;51(6):1617\u201323.","journal-title":"Hypertension"},{"issue":"1","key":"569_CR76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.atherosclerosis.2011.06.007","volume":"219","author":"T Nakamura","year":"2011","unstructured":"Nakamura T et al. Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: a randomized, double-blind, placebo-controlled trial. Atherosclerosis. 2011;219(1):298\u2013303.","journal-title":"Atherosclerosis"},{"issue":"3","key":"569_CR77","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/1074248413511692","volume":"19","author":"H Uzui","year":"2014","unstructured":"Uzui H et al. Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension. J Cardiovasc Pharmacol Ther. 2014;19(3):304\u20139.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"569_CR78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/HJH.0000000000000014","volume":"32","author":"P Boutouyrie","year":"2014","unstructured":"Boutouyrie P et al. Destiffening effect of valsartan and atenolol: influence of heart rate and blood pressure. J Hypertens. 2014;32(1):108\u201314.","journal-title":"J Hypertens"},{"issue":"2","key":"569_CR79","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jash.2013.09.001","volume":"8","author":"C Koumaras","year":"2014","unstructured":"Koumaras C et al. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness. J Am Soc Hypertens. 2014;8(2):74\u201382.","journal-title":"J Am Soc Hypertens"},{"issue":"6","key":"569_CR80","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/HYPERTENSIONAHA.106.085738","volume":"49","author":"GF Mitchell","year":"2007","unstructured":"Mitchell GF et al. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension. 2007;49(6):1271\u20137.","journal-title":"Hypertension"},{"issue":"1","key":"569_CR81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.109.132670","volume":"54","author":"N Dhaun","year":"2009","unstructured":"Dhaun N et al. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension. 2009;54(1):113\u20139.","journal-title":"Hypertension"},{"issue":"7","key":"569_CR82","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1532-5415.2010.02905.x","volume":"58","author":"PA Kithas","year":"2010","unstructured":"Kithas PA, Supiano MA. Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension. J Am Geriatr Soc. 2010;58(7):1327\u201332.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"569_CR83","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2125.2005.02363.x","volume":"59","author":"J Davies","year":"2005","unstructured":"Davies J et al. Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients. Br J Clin Pharmacol. 2005;59(5):520\u20133.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"569_CR84","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1191\/1358863x03vm509ra","volume":"8","author":"C Vlachopoulos","year":"2003","unstructured":"Vlachopoulos C, Hirata K, O\u2019Rourke MF. Effect of sildenafil on arterial stiffness and wave reflection. Vasc Med. 2003;8(4):243\u20138.","journal-title":"Vasc Med"},{"issue":"8","key":"569_CR85","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/0091270011413586","volume":"52","author":"C Vlachopoulos","year":"2012","unstructured":"Vlachopoulos C et al. Beneficial effect of vardenafil on aortic stiffness and wave reflections. J Clin Pharmacol. 2012;52(8):1215\u201321.","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"569_CR86","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/ndt\/17.8.1513","volume":"17","author":"A Ichihara","year":"2002","unstructured":"Ichihara A et al. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant. 2002;17(8):1513\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"569_CR87","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/jhh.2011.80","volume":"26","author":"AI Kanaki","year":"2012","unstructured":"Kanaki AI et al. Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study. J Hum Hypertens. 2012;26(10):577\u201384.","journal-title":"J Hum Hypertens"},{"issue":"11","key":"569_CR88","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.jacc.2005.06.084","volume":"46","author":"H Yokoyama","year":"2005","unstructured":"Yokoyama H et al. Effects of fluvastatin on the carotid arterial media as assessed by integrated backscatter ultrasound compared with pulse-wave velocity. J Am Coll Cardiol. 2005;46(11):2031\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"569_CR89","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.jhh.1001786","volume":"19","author":"A Ichihara","year":"2005","unstructured":"Ichihara A et al. Long-term effects of statins on arterial pressure and stiffness of hypertensives. J Hum Hypertens. 2005;19(2):103\u20139.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"569_CR90","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/HYPERTENSIONAHA.109.138248","volume":"54","author":"JS Orr","year":"2009","unstructured":"Orr JS et al. Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults. Hypertension. 2009;54(4):763\u20138.","journal-title":"Hypertension"},{"issue":"6","key":"569_CR91","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0735-1097(02)01717-5","volume":"39","author":"KE Ferrier","year":"2002","unstructured":"Ferrier KE et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol. 2002;39(6):1020\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"569_CR92","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2169\/internalmedicine.52.0731","volume":"52","author":"B Liu","year":"2013","unstructured":"Liu B et al. Effects of rosuvastatin vs. simvastatin\/ezetimibe on arterial wall stiffness in patients with coronary artery disease. Intern Med. 2013;52(24):2715\u20139.","journal-title":"Intern Med"},{"issue":"3","key":"569_CR93","doi-asserted-by":"crossref","first-page":"e91961","DOI":"10.1371\/journal.pone.0091961","volume":"9","author":"KP Ng","year":"2014","unstructured":"Ng KP et al. Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study. PLoS One. 2014;9(3):e91961.","journal-title":"PLoS One"},{"issue":"6","key":"569_CR94","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacc.2009.03.066","volume":"54","author":"NC Edwards","year":"2009","unstructured":"Edwards NC et al. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol. 2009;54(6):505\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"569_CR95","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1097\/HJH.0b013e32833da2b2","volume":"28","author":"H Ait-Oufella","year":"2010","unstructured":"Ait-Oufella H et al. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens. 2010;28(11):2336\u201341.","journal-title":"J Hypertens"},{"issue":"1","key":"569_CR96","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2011.12.005","volume":"221","author":"Y Shahin","year":"2012","unstructured":"Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2012;221(1):18\u201333.","journal-title":"Atherosclerosis"},{"issue":"5","key":"569_CR97","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2174\/157016110792006950","volume":"8","author":"EC Rizos","year":"2010","unstructured":"Rizos EC, Agouridis AP, Elisaf MS. The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review. Curr Vasc Pharmacol. 2010;8(5):638\u201344.","journal-title":"Curr Vasc Pharmacol"},{"issue":"7","key":"569_CR98","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1681\/ASN.2010111185","volume":"22","author":"MP Kao","year":"2011","unstructured":"Kao MP et al. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol. 2011;22(7):1382\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"569_CR99","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hc3801.097806","volume":"104","author":"DA Kass","year":"2001","unstructured":"Kass DA et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001;104(13):1464\u201370.","journal-title":"Circulation"},{"issue":"3","key":"569_CR100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/HJH.0b013e328013e7dd","volume":"25","author":"SJ Zieman","year":"2007","unstructured":"Zieman SJ et al. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens. 2007;25(3):577\u201383.","journal-title":"J Hypertens"},{"issue":"6","key":"569_CR101","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCHEARTFAILURE.113.000440","volume":"6","author":"N Fujimoto","year":"2013","unstructured":"Fujimoto N et al. Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals. Circ Heart Fail. 2013;6(6):1155\u201364.","journal-title":"Circ Heart Fail"},{"issue":"12","key":"569_CR102","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.exger.2013.10.009","volume":"48","author":"MH Oudegeest-Sander","year":"2013","unstructured":"Oudegeest-Sander MH et al. The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial. Exp Gerontol. 2013;48(12):1509\u201317.","journal-title":"Exp Gerontol"},{"issue":"8","key":"569_CR103","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/eurjhf\/hfr067","volume":"13","author":"JW Hartog","year":"2011","unstructured":"Hartog JW et al. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail. 2011;13(8):899\u2013908.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"569_CR104","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.numecd.2014.01.015","volume":"24","author":"M Lilamand","year":"2014","unstructured":"Lilamand M et al. Flavonoids and arterial stiffness: promising perspectives. Nutr Metab Cardiovasc Dis. 2014;24(7):698\u2013704.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"569_CR105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ajh\/hpt176","volume":"27","author":"G Siasos","year":"2014","unstructured":"Siasos G et al. Favorable effects of concord grape juice on endothelial function and arterial stiffness in healthy smokers. Am J Hypertens. 2014;27(1):38\u201345.","journal-title":"Am J Hypertens"},{"issue":"2","key":"569_CR106","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3945\/ajcn.110.002725","volume":"93","author":"MP Pase","year":"2011","unstructured":"Pase MP, Grima NA, Sarris J. The effects of dietary and nutrient interventions on arterial stiffness: a systematic review. Am J Clin Nutr. 2011;93(2):446\u201354.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"569_CR107","doi-asserted-by":"crossref","first-page":"H1211","DOI":"10.1152\/ajpheart.01065.2011","volume":"302","author":"KL Moreau","year":"2012","unstructured":"Moreau KL et al. Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Am J Physiol Heart Circ Physiol. 2012;302(5):H1211\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"569_CR108","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ajh.2012.70","volume":"25","author":"GL Pierce","year":"2012","unstructured":"Pierce GL et al. Tetrahydrobiopterin supplementation enhances carotid artery compliance in healthy older men: a pilot study. Am J Hypertens. 2012;25(10):1050\u20134.","journal-title":"Am J Hypertens"},{"issue":"2","key":"569_CR109","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/HYPERTENSIONAHA.112.194456","volume":"60","author":"S Laurent","year":"2012","unstructured":"Laurent S, Briet M, Boutouyrie P. Arterial stiffness as surrogate end point: needed clinical trials. Hypertension. 2012;60(2):518\u201322. A well written review article to address the issues surrounding the use of arterial stiffness as a biomarker in clinical trials.","journal-title":"Hypertension"},{"issue":"5","key":"569_CR110","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/HYPERTENSIONAHA.113.02955","volume":"63","author":"H Fok","year":"2014","unstructured":"Fok H et al. Augmentation pressure is influenced by ventricular contractility\/relaxation dynamics: novel mechanism of reduction of pulse pressure by nitrates. Hypertension. 2014;63(5):1050\u20135.\u00a0This study introduces the novel concept of LV contractility \/ dynamics as an important component of the BP lowering properties of organic nitrate (GTN).","journal-title":"Hypertension"},{"issue":"2","key":"569_CR111","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/cvr\/20.2.153","volume":"20","author":"T Yaginuma","year":"1986","unstructured":"Yaginuma T et al. Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res. 1986;20(2):153\u201360.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"569_CR112","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/hrt.2004.057356","volume":"91","author":"AL Pauca","year":"2005","unstructured":"Pauca AL, Kon ND, O\u2019Rourke MF. Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries. Heart. 2005;91(11):1428\u201332.","journal-title":"Heart"},{"issue":"8","key":"569_CR113","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jacc.2009.04.068","volume":"54","author":"M Cecelja","year":"2009","unstructured":"Cecelja M et al. Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions: a twin study. J Am Coll Cardiol. 2009;54(8):695\u2013703.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"569_CR114","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.109.134379","volume":"54","author":"AP Avolio","year":"2009","unstructured":"Avolio AP et al. Role of pulse pressure amplification in arterial hypertension: experts\u2019 opinion and review of the data. Hypertension. 2009;54(2):375\u201383.","journal-title":"Hypertension"},{"issue":"15","key":"569_CR115","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/eurheartj\/ehq024","volume":"31","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31(15):1865\u201371.","journal-title":"Eur Heart J"},{"issue":"9","key":"569_CR116","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","volume":"113","author":"B Williams","year":"2006","unstructured":"Williams B et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation. 2006;113(9):1213\u201325.","journal-title":"Circulation"},{"issue":"2","key":"569_CR117","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/HYPERTENSIONAHA.109.133801","volume":"54","author":"IS Mackenzie","year":"2009","unstructured":"Mackenzie IS et al. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension. 2009;54(2):409\u201313.","journal-title":"Hypertension"},{"issue":"2","key":"569_CR118","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.amjhyper.2003.09.012","volume":"17","author":"T Morgan","year":"2004","unstructured":"Morgan T et al. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17(2):118\u201323.","journal-title":"Am J Hypertens"},{"issue":"4","key":"569_CR119","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/hy1001.095774","volume":"38","author":"RG Asmar","year":"2001","unstructured":"Asmar RG et al. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril\/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension. 2001;38(4):922\u20136.","journal-title":"Hypertension"},{"issue":"5","key":"569_CR120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/CS20020091","volume":"103","author":"AJ Deary","year":"2002","unstructured":"Deary AJ et al. Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci (Lond). 2002;103(5):493\u20139.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"569_CR121","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2125.1982.tb01968.x","volume":"14","author":"AC Simon","year":"1982","unstructured":"Simon AC et al. Effect of nitroglycerin on peripheral large arteries in hypertension. Br J Clin Pharmacol. 1982;14(2):241\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"569_CR122","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/hy1001.096106","volume":"38","author":"AL Pauca","year":"2001","unstructured":"Pauca AL, O\u2019Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38(4):932\u20137.","journal-title":"Hypertension"},{"issue":"5","key":"569_CR123","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/HYPERTENSIONAHA.112.198788","volume":"60","author":"H Fok","year":"2012","unstructured":"Fok H et al. Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels. Hypertension. 2012;60(5):1220\u20135.","journal-title":"Hypertension"},{"issue":"2","key":"569_CR124","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/heart.88.2.143","volume":"88","author":"XJ Jiang","year":"2002","unstructured":"Jiang XJ et al. Quantification of glyceryl trinitrate effect through analysis of the synthesised ascending aortic pressure waveform. Heart. 2002;88(2):143\u20138.","journal-title":"Heart"},{"issue":"6","key":"569_CR125","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/01.HYP.37.6.1429","volume":"37","author":"RP Kelly","year":"2001","unstructured":"Kelly RP et al. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001;37(6):1429\u201333.","journal-title":"Hypertension"},{"issue":"5 Pt 2","key":"569_CR126","first-page":"III63","volume":"5","author":"ME Safar","year":"1983","unstructured":"Safar ME et al. Peripheral large arteries and the response to antihypertensive treatment. Hypertension. 1983;5(5 Pt 2):III63\u20138.","journal-title":"Hypertension"},{"issue":"4","key":"569_CR127","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00005344-198307000-00018","volume":"5","author":"AC Simon","year":"1983","unstructured":"Simon AC et al. Action of vasodilating drugs on small and large arteries of hypertensive patients. J Cardiovasc Pharmacol. 1983;5(4):626\u201331.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"569_CR128","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/00005344-198509000-00007","volume":"7","author":"AC Simon","year":"1985","unstructured":"Simon AC et al. Effects of chronic administration of enalapril and propranolol on the large arteries in essential hypertension. J Cardiovasc Pharmacol. 1985;7(5):856\u201361.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 1","key":"569_CR129","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/00005344-198507001-00010","volume":"7","author":"AC Simon","year":"1985","unstructured":"Simon AC et al. Effects of acute and chronic angiotensin-converting enzyme inhibition on large arteries in human hypertension. J Cardiovasc Pharmacol. 1985;7 Suppl 1:S45\u201351.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 4","key":"569_CR130","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1097\/00005344-198608004-00012","volume":"8","author":"BL Maarek","year":"1986","unstructured":"Maarek BL et al. Comparative effects of propranolol and pindolol on small and large arteries and veins of the forearm circulation in hypertensive man. J Cardiovasc Pharmacol. 1986;8 Suppl 4:S61\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"569_CR131","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00004872-199917050-00015","volume":"17","author":"LM Bortel Van","year":"1999","unstructured":"Van Bortel LM et al. Is it possible to develop drugs that act more selectively on large arteries? J Hypertens. 1999;17(5):701\u20135.","journal-title":"J Hypertens"},{"issue":"4","key":"569_CR132","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.114.009554","volume":"131","author":"SA Omar","year":"2015","unstructured":"Omar SA et al. Paradoxical normoxia-dependent selective actions of inorganic nitrite in human muscular conduit arteries and related selective actions on central blood pressures. Circulation. 2015;131(4):381\u20139.","journal-title":"Circulation"},{"issue":"3","key":"569_CR133","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/HYPERTENSIONAHA.108.116525","volume":"52","author":"BE Westerhof","year":"2008","unstructured":"Westerhof BE et al. Location of a reflection site is elusive: consequences for the calculation of aortic pulse wave velocity. Hypertension. 2008;52(3):478\u201383.","journal-title":"Hypertension"},{"issue":"3","key":"569_CR134","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/HYPERTENSIONAHA.111.180604","volume":"60","author":"JE Davies","year":"2012","unstructured":"Davies JE et al. Attenuation of wave reflection by wave entrapment creates a \u201chorizon effect\u201d in the human aorta. Hypertension. 2012;60(3):778\u201385.","journal-title":"Hypertension"},{"issue":"2","key":"569_CR135","doi-asserted-by":"crossref","first-page":"H580","DOI":"10.1152\/ajpheart.00875.2009","volume":"298","author":"JE Davies","year":"2010","unstructured":"Davies JE et al. The arterial reservoir pressure increases with aging and is the major determinant of the aortic augmentation index. Am J Physiol Heart Circ Physiol. 2010;298(2):H580\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"569_CR136","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1088\/0967-3334\/28\/9\/006","volume":"28","author":"P Segers","year":"2007","unstructured":"Segers P et al. Assessment of pressure wave reflection: getting the timing right! Physiol Meas. 2007;28(9):1045\u201356.","journal-title":"Physiol Meas"},{"issue":"3","key":"569_CR137","doi-asserted-by":"crossref","first-page":"e59371","DOI":"10.1371\/journal.pone.0059371","volume":"8","author":"AD Hughes","year":"2013","unstructured":"Hughes AD et al. Limitations of augmentation index in the assessment of wave reflection in normotensive healthy individuals. PLoS One. 2013;8(3):e59371. This study provides further evidence on the limitation of augmentation index as a marker of pressure wave reflection.","journal-title":"PLoS One"},{"issue":"5","key":"569_CR138","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/HYPERTENSIONAHA.114.04050","volume":"64","author":"H Fok","year":"2014","unstructured":"Fok H et al. Dominance of the forward compression wave in determining pulsatile components of blood pressure: similarities between inotropic stimulation and essential hypertension. Hypertension. 2014;64(5):1116\u201323.","journal-title":"Hypertension"},{"issue":"1","key":"569_CR139","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/HYPERTENSIONAHA.111.00584","volume":"62","author":"MG Schultz","year":"2013","unstructured":"Schultz MG et al. Exercise central (aortic) blood pressure is predominantly driven by forward traveling waves, not wave reflection. Hypertension. 2013;62(1):175\u201382.","journal-title":"Hypertension"},{"issue":"2","key":"569_CR140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.114.03371","volume":"64","author":"AA Torjesen","year":"2014","unstructured":"Torjesen AA et al. Forward and backward wave morphology and central pressure augmentation in men and women in the Framingham Heart Study. Hypertension. 2014;64(2):259\u201365.","journal-title":"Hypertension"},{"issue":"2","key":"569_CR141","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/HYPERTENSIONAHA.110.153536","volume":"56","author":"V Kapil","year":"2010","unstructured":"Kapil V et al. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension. 2010;56(2):274\u201381.","journal-title":"Hypertension"},{"issue":"2","key":"569_CR142","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/HYPERTENSIONAHA.114.04675","volume":"65","author":"V Kapil","year":"2015","unstructured":"Kapil V et al. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension. 2015;65(2):320\u20137.","journal-title":"Hypertension"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-015-0569-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-015-0569-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-015-0569-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:39Z","timestamp":1559434479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-015-0569-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":142,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1007\/s11906-015-0569-6","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]},"article-number":"67"}}